SGHT logo

Sight Sciences (SGHT)

Profile

Full Name

Sight Sciences, Inc.

Ticker Symbol

SGHT

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 15, 2021

Indexes

Not included

Website

http://www.sightsciences.com

Employees

216

Key Details

Price

$2.48(-1.39%)

Market cap

$127.56M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$79.87M(-1.47% YoY)

Annual EPS

-$1.03(+9.65% YoY)

PE ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.48
SGHT price is $2.48

30-Day Relative Volume

1.16
SGHT 30-day relative volume is 1.16

Price Performance

Price Today change

-1.39%
SGHT price is down -1.39% today

Price YTD change

-31.73%
SGHT price is down -31.73% since January 1st

Price 1-year change

-52.49%
SGHT price is down -52.49% year-on-year

Price 3-year change

-73.14%
SGHT price is down -73.14% over the past 3 years

Price Range

Price All-time high

$42.57
SGHT price is currently -94.16% below its historical high of $42.57

Price 3-year low

$1.04
SGHT price is currently +138.94% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$127.56M
SGHT market capitalization is $127.56 million

Market cap 3-year change

-71.02%
SGHT market capitalization is down -71.02% over the past 3 years

Market cap All-time high

$1.83B
SGHT market capitalization is currently -93.02% below its historical high of $1.83 billion

Market cap sector rank

51.56%
SGHT market capitalization is higher than 51.56% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.19%
SGHT shares outstanding is up +3.19% year-on-year

Shares Outstanding 3-Year Change

+7.86%
SGHT shares outstanding is up +7.86% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.30
SGHT beta is 1.30

200-day SMA

$4.62
SGHT price is currently -46.16% below its 200-day simple moving average

50-day SMA

$2.59
SGHT price is currently -4.04% below its 50-day simple moving average

RSI

50.96
SGHT 14-day relative strength index is 50.96

Volume

1.16
SGHT 30-day relative volume is 1.16

ATR

$0.25
SGHT average true range is $0.25

10-day Historical Volatility

86.40%
SGHT 10-day historical volatility is 86.40%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$79.87M
SGHT annual revenue is $79.87 million

Revenue Analysts estimate

$71.92M
SGHT annual revenue is currently +11.05% higher than the consensus analysts' forecast

Revenue 1-year change

-1.47%
SGHT annual revenue is down -1.47% year-on-year

Revenue Sector rank

53.3%
SGHT annual revenue is higher than 53.3% of companies in Healthcare sector

EPS

EPS

-$1.03
SGHT annual earnings per share is -$1.03

EPS Analysts estimate

-$0.99
SGHT annual earnings per share is currently +4.40% higher than the consensus analysts' forecast

EPS 1-year change

+9.65%
SGHT annual earnings per share is up +9.65% year-on-year

EPS Sector rank

55.84%
SGHT annual earnings per share is higher than 55.84% of companies in Healthcare sector

Profit

Gross profit

$68.28M
SGHT annual gross profit is $68.28 million

Gross margin

85.50%
SGHT annual gross profit margin is 85.50%

Operating profit

-$50.53M
SGHT annual operating income is -$50.53 million

Operating margin

-63.27%
SGHT annual operating profit margin is -63.27%

Net income

-$51.51M
SGHT annual net profit is -$51.51 million

Net margin

-64.49%
SGHT annual net profit margin is -64.49%

Expenses

Total expenses

$130.40M
SGHT annual total expenses is $130.40 million

Operating expenses

$118.82M
SGHT annual total operating expenses is $118.82 million

Cost of goods sold

$11.58M
SGHT annual cost of goods sold is $11.58 million

Selling, general & administrative expenses

$100.83M
SGHT annual SGA is $100.83 million

Depreciation and amortization

$712.00K
SGHT annual depreciation & amortization is $712.00 thousand

Interest expense

$4.66M
SGHT annual interest expense is $4.66 million

Income tax

$236.00K
SGHT annual income tax is $236.00 thousand

EBIT & EBITDA

EBIT

-$46.61M
SGHT annual earnings before interest & taxes is -$46.61 million

EBITDA

-$46.61M
SGHT annual EBITDA is -$46.61 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$142.84M
SGHT annual total assets is $142.84 million

Non current assets

$3.06M
SGHT annual long term assets is $3.06 million

Current assets

$139.77M
SGHT annual total current assets is $139.77 million

Cash and cash equivalents

$120.36M
SGHT annual cash & cash equivalents is $120.36 million

Accounts receivable

$10.79M
SGHT annual accounts receivable is $10.79 million

Inventory

$6.33M
SGHT annual inventory is $6.33 million

Liabilities

Total liabilities

$55.32M
SGHT annual total liabilities is $55.32 million

Long term liabilities

$39.85M
SGHT annual total long term liabilities is $39.85 million

Current liabilities

$15.47M
SGHT annual total current liabilities is $15.47 million

Accounts payable

$1.69M
SGHT annual accounts payable is $1.69 million

Debt

Total debt

$39.89M
SGHT annual total debt is $39.89 million

Total debt 1-year change

+12.64%
SGHT annual total debt is up +12.64% year-on-year

Long term debt

$39.36M
SGHT annual long term debt is $39.36 million

Short term debt

$533.00K
SGHT annual short term debt is $533.00 thousand

Equity & Capital

Shareholders equity

$87.52M
SGHT annual stockholders equity is $87.52 million

Book value

$87.52M
SGHT annual book value is $87.52 million

Retained earnings

-$346.30M
SGHT annual retained earnings is -$346.30 million

Working capital

$124.31M
SGHT annual working capital is $124.31 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$22.35M
SGHT annual cash flow from operations is -$22.35 million

Cash from operations 1-year change

+52.63%
SGHT annual cash flow from operations is up +52.63% year-on-year

Cash from investing

-$385.00K
SGHT annual cash flow from investing activities is -$385.00 thousand

Cash from investing 1-year change

+51.33%
SGHT annual cash flow from investing activities is up +51.33% year-on-year

Cash from financing

$4.96M
SGHT annual cash flow from financing activities is $4.96 million

Cash from financing 1-year change

+349.64%
SGHT annual cash flow from financing activities is up +349.64% year-on-year

CAPEX

CAPEX

$385.00K
SGHT annual capital expenditures is $385.00 thousand

CAPEX 1-year change

-51.33%
SGHT annual capital expenditures is down -51.33% year-on-year

Free Cash Flow

Free cash flow

-$22.74M
SGHT annual free cash flow is -$22.74 million

Free cash flow 1-year change

+52.61%
SGHT annual free cash flow is up +52.61% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

85.50%
SGHT annual gross profit margin is 85.50%

Operating margin

-63.27%
SGHT annual operating profit margin is -63.27%

Net margin

-64.49%
SGHT annual net profit margin is -64.49%

ROA & ROE

ROA

-33.29%
SGHT annual return on assets is -33.29%

ROE

-49.59%
SGHT annual return on equity is -49.59%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SGHT price to earnings ratio value is unknown

PE ratio Sector rank

-
SGHT price to earnings ratio is unknown

PB Ratio

PB ratio

1.46
SGHT price to book ratio is 1.46

PB ratio Sector rank

55.06%
SGHT price to book ratio is higher than 55.06% of companies in Healthcare sector

PS Ratio

PS ratio

1.60
SGHT price to sales ratio is 1.60

PS ratio Sector rank

38.33%
SGHT price to sales ratio is higher than 38.33% of companies in Healthcare sector

Enterprise value

Enterprise value

$47.57M
SGHT enterprise value is $47.57 million

Enterprise value Sector rank

41.03%
SGHT enterprise value is higher than 41.03% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.03
SGHT EV/EBITDA is -1.03

EV/EBITDA Sector rank

42.12%
SGHT EV/EBITDA is higher than 42.12% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.04
SGHT annual current ratio is 9.04

Quick ratio

8.63
SGHT annual quick ratio is 8.63

Leverage

Debt to equity

0.45
SGHT annual debt to equity ratio is 0.45

Interest coverage ratio

-10.00
SGHT annual interest coverage ratio is -10.00

Risk & Stability

Piotroski F-Score

3
SGHT piotroski f-score is 3

Altman Z-Score

-1.48
SGHT altman z-score is -1.48

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Hold
Mar 6, 25 Stifel
Buy
Mar 6, 25 Piper Sandler
Neutral
Mar 6, 25 Needham
Hold
Mar 6, 25 Lake Street
Hold
Mar 4, 25 Citigroup
Neutral
Feb 6, 25 Stifel
Buy
Jan 27, 25 UBS
Buy
Jan 15, 25 Lake Street
Hold
Jan 14, 25 Needham
Hold

Institutional Ownership

Similar stocks

RGLS logo
Regulus Therapeutics (RGLS)
CGEN logo
Compugen (CGEN)
FATE logo
Fate Therapeutics (FATE)
OGI logo
OrganiGram Holdings (OGI)
ALDX logo
Aldeyra Therapeutics (ALDX)
SLN logo
Silence Therapeutics (SLN)
KRRO logo
Korro Bio (KRRO)
SCPH logo
scPharmaceuticals (SCPH)
ZJYL logo
Jin Medical International (ZJYL)
  • What is the ticker symbol for Sight Sciences?
  • Does Sight Sciences pay dividends?
  • What sector is Sight Sciences in?
  • What industry is Sight Sciences in?
  • What country is Sight Sciences based in?
  • When did Sight Sciences go public?
  • Is Sight Sciences in the S&P 500?
  • Is Sight Sciences in the NASDAQ 100?
  • Is Sight Sciences in the Dow Jones?
  • When was Sight Sciences's last earnings report?
  • When does Sight Sciences report earnings?
  • Should I buy Sight Sciences stock now?

What is the ticker symbol for Sight Sciences?

The ticker symbol for Sight Sciences is NASDAQ:SGHT

Does Sight Sciences pay dividends?

No, Sight Sciences does not pay dividends

What sector is Sight Sciences in?

Sight Sciences is in the Healthcare sector

What industry is Sight Sciences in?

Sight Sciences is in the Medical Devices industry

What country is Sight Sciences based in?

Sight Sciences is headquartered in United States

When did Sight Sciences go public?

Sight Sciences's initial public offering (IPO) was on July 15, 2021

Is Sight Sciences in the S&P 500?

No, Sight Sciences is not included in the S&P 500 index

Is Sight Sciences in the NASDAQ 100?

No, Sight Sciences is not included in the NASDAQ 100 index

Is Sight Sciences in the Dow Jones?

No, Sight Sciences is not included in the Dow Jones index

When was Sight Sciences's last earnings report?

Sight Sciences's most recent earnings report was on Mar 5, 2025

When does Sight Sciences report earnings?

The next expected earnings date for Sight Sciences is May 2, 2025

Should I buy Sight Sciences stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page